VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $5.23M invested in VistaGen Therapeutics in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.18% more ownership

Funds ownership: 0.54% → 0.72% (+0.18%)

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.35M
2
+$926K
3
+$210K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
+$65.9K
5
AWCI
Alpine Woods Capital Investors
New York
+$50K

Top Sellers

1
-$255K
2
-$65K
3
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.35M
2
$1.38M
3
$926K
4
$154K
5
$116K
6
$109K
7
$50K
8
$49K
9
$33K
10
$22K
11
$17K
12
$12K
13
$3K
14
$1K
15
–
16
–